A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's DiseaseSofia Tzimopoulou, Paul M. Matthews, Thomas E. Nichols et al.|Journal of Alzheimer s Disease|2011Cited by 109